Nuvation Bio Inc (NUVB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | NUVB | RARE | CGON | ||
| Company | Nuvation Bio Inc | Ultragenyx Pharmaceu | Cg Oncology Inc | ||
| Price Information | |||||
| Exchange | NYSE | NASDAQ | NASDAQ | ||
| Open | 9.54 | 34.38 | 39.83 | ||
| High | 9.56 | 34.47 | 40.47 | ||
| Low | 9.26 | 33.90 | 39.47 | ||
| Latest | 9.40 | 34.19 | 39.84 | ||
| Change | -0.12 | -0.39 | -0.30 | ||
| % Change | -1.26% | -1.13% | -0.75% | ||
| Volume | 3,602,000 | 629,200 | 561,900 | ||
| 20-Day Average Volume | 5,972,210 | 1,474,535 | 830,450 | ||
| Previous Close | 9.52 | 34.58 | 40.14 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 8.58 | 35.00 | 41.05 | ||
| 20-Day Raw Stochastic | 84.75% | 21.38% | 31.44% | ||
| 20-Day Relative Strength | 70.42 | 50.72 | 47.73 | ||
| Weighted Alpha | +228.94 | -8.67 | +56.27 | ||
| Today's Opinion | 100% Buy | 64% Buy | 40% Buy | ||
| Previous Opinion | 100% Buy | 64% Buy | 40% Buy | ||
| Last Month's Opinion | 100% Buy | 16% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +4.56% since 12/18/25 | +4.11% since 12/18/25 | +4.84% since 12/18/25 | ||
| Low | 9.01 on 12/19/25 | 32.65 on 12/19/25 | 37.73 on 12/19/25 | ||
| High | 9.75 on 12/22/25 | 35.12 on 12/22/25 | 40.95 on 12/22/25 | ||
| 1-Month | |||||
| %Chg | +17.35% since 11/26/25 | +1.27% since 11/26/25 | -11.15% since 11/26/25 | ||
| Low | 7.45 on 12/02/25 | 32.64 on 12/18/25 | 37.01 on 12/17/25 | ||
| High | 9.75 on 12/22/25 | 39.89 on 12/08/25 | 46.01 on 12/05/25 | ||
| 3-Month | |||||
| %Chg | +193.75% since 09/26/25 | +17.57% since 09/26/25 | +6.13% since 09/26/25 | ||
| Low | 3.15 on 09/29/25 | 28.56 on 11/05/25 | 35.80 on 11/11/25 | ||
| High | 9.75 on 12/22/25 | 39.89 on 12/08/25 | 46.01 on 12/05/25 | ||
| 6-Month | |||||
| %Chg | +377.16% since 06/26/25 | -7.89% since 06/26/25 | +52.82% since 06/26/25 | ||
| Low | 1.87 on 07/01/25 | 25.81 on 07/21/25 | 23.65 on 08/11/25 | ||
| High | 9.75 on 12/22/25 | 42.37 on 07/09/25 | 46.01 on 12/05/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 3,263,770 | 3,336,209 | 3,237,933 | ||
| Shares Outstanding, K | 342,833 | 96,478 | 80,666 | ||
| Annual Sales | 7,870,000 | 560,230,000 | 1,140,000 | ||
| Annual Net Income | -567,940,000 | -569,180,000 | -88,040,000 | ||
| Last Quarter Sales | 13,120,000 | 159,930,000 | 1,670,000 | ||
| Last Quarter Net Income | -55,790,000 | -180,410,000 | -43,810,000 | ||
| 60-Month Beta | 1.58 | 0.16 | 1.29 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.16 on 11/03/25 | -1.81 on 11/04/25 | -0.57 on 11/14/25 | ||
| Latest Earnings Date | 03/05/26 | 02/12/26 | 03/27/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||